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Abstract 
Background: Some mothers of children with attention-deficit/hyperactivity disorder 
(ADHD) present with maladaptive personality profiles (high neuroticism, low 
conscientiousness). The moderating effect of maternal personality traits on treatment 
outcomes for childhood ADHD has not been examined. We evaluate whether maternal 
neuroticism and conscientiousness moderated response in the Multimodal Treatment Study of 
Children with ADHD. This is one of the first study of this type. 
Methods: In a randomized controlled trial (RCT), 579 children ages 7-10 (M=8.5); 19.7% 
female; 60.8% White with combined-type ADHD were randomly assigned to systematic 
medication management (MedMgt) alone, comprehensive multicomponent behavioral 
treatment (Beh), their combination (Comb), or community comparison treatment-as-usual 
(CC). Latent Class Analysis and Linear Mixed Effects Models included 437 children whose 
biological mothers completed the NEO Five-Factor Inventory at baseline.  
Results: A 3-class solution demonstrated best fit for the NEO: MN&MC=moderate 
neuroticism and conscientiousness (n=284); HN&LC=high neuroticism, low 
conscientiousness (n=83); LN&HC=low neuroticism, high conscientiousness (n=70). Per 
parent-reported symptoms: children of mothers with HN&LC, but not LN&HC, had a 
significantly better response to Beh than to CC; Children of mothers with MN&MC and 
LN&HC, but not HN&LC, responded better to Comb&MedMgt than to Beh&CC. Per 
teacher-reported symptoms, children of mothers with HN&LC, but not LN&HC, responded 
significantly better to Comb than to MedMgt.  
Conclusions: Children of mothers with high neuroticism and low conscientiousness 
benefited more from behavioral treatments (Beh vs. CC; Comb vs. MedMgt) than other 
children. Evaluation of maternal personality may aid treatment selection for children with 
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ADHD, though additional research on this topic is needed.   
Keywords: attention-deficit/hyperactivity disorder, maternal personality traits, neuroticism, 
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Introduction 
Despite strengths of existing evidence-based pharmacological and psychosocial 
treatments for attention-deficit/hyperactivity disorder (ADHD) and disruptive behavior 
disorders, a substantial number of children fail to respond adequately. Approximately one-
third of children receiving well-managed FDA-approved medication for ADHD do not fully 
benefit even when augmented with behavioral treatment [1]. In addition, those who 
demonstrate good initial response may not show sustained benefit beyond two years [2,3]. 
Thus, enhanced understanding of the relative efficacy of interventions for ADHD and 
disruptive behavior disorders is needed. 
Family preferences, characteristics, and resources can influence the effects of 
interventions [4-7]. For example, some families may refuse medications or struggle to 
manage the demands of behavioral treatments amidst a chaotic home environment, 
psychosocial stressors, or parental psychopathology [6,8-10]. Therefore, a “one size fits all” 
approach to treatment may lead to a mismatch between families and interventions [11,12]. 
Attending to child and family characteristics in treatment selection may improve long-term 
outcomes [13], which at this point are suboptimal for many.  
 The identification of treatment moderators may offer one means of intervention 
tailoring and matching, by identifying subgroups for whom particular treatments are more or 
less effective [5,14,15]. Such an approach may ultimately enhance the relative efficacy of 
selected treatments for specific patient populations and facilitate the allocation of limited 
resources, thereby optimizing outcomes for children and families.  
For instance, parental cognitions, attributions, and perceptions have been found to 
play a role in the therapist-caregiver relationship and influence treatment engagement, 
compliance, and decisions about continuation vs. termination of services [16-18]. Parental 
psychosocial factors and mental health issues may be particularly relevant to treatments for 
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disruptive behavior disorders and ADHD in children, which require substantial parent 
engagement and oversight. For example, in randomized controlled trials (RCTs) of 
interventions for disruptive behavior disorders in children, low marital adjustment, higher 
maternal depression, lower familial social class, presence of paternal substance use, and 
single-mother households were associated with enhanced response to evidence-based 
psychosocial treatments with parent- and/or child-focused components [5]. In addition, parent 
training was least effective for economically disadvantaged families, though these families 
seemed to benefit more from individual vs. group delivery format [8]. For adolescents with 
conduct problems, Multisystemic Therapy was more effective when fathers were involved in 
treatment [9]. Thus, parent/family psychosocial and psychopathological factors play an 
important role in the relative efficacy of interventions for disruptive behavior disorders 
[5,8,9]. 
Such parent/family variables are also relevant in the treatment of childhood ADHD. 
For example, high parental anxiety/depression predicted poor response to behavioral 
interventions in one RCT [6]. In the Multimodal Treatment Study of ADHD (MTA), higher 
parental education was associated with enhanced response of children’s ADHD symptoms to 
combination treatment (Comb—medication management and multicomponent behavioral 
treatment); children from blue-collar and lower SES homes similarly benefited most from 
Comb in terms of oppositional-aggressive symptoms [10]. Also in the MTA, parental 
depressive symptoms were associated with worse response to MedMgt, but not Comb [7]. 
The lack of behavioral support for parents in the MedMgt group may explain the apparent 
discrepancy with findings reported in Beauchaine et al. [5], who found maternal depression 
associated with a better response to behavioral intervention.   In addition, ethnicity moderated 
outcomes in the MTA, such that ethnic minority families (African American, Latino) 
benefitted most from Comb [19]. Although exceptions to these findings exist [20], parental 
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psychosocial factors and psychiatric symptoms are implicated in the phenomenology and 
treatment response among children with ADHD [6,7,10,19].  
Maladaptive parental personality traits may also play a role in response to childhood 
ADHD treatments. Certain maladaptive personality dimensions have been found to both 
predict and moderate treatment response for childhood problems other than ADHD. One 
study found that elevated Cluster B personality disorder (antisocial, borderline, narcissistic, 
histrionic) symptoms in parents predicted poor response across treatment conditions in a RCT 
for children with depressive and bipolar disorders [21]. In a RCT of the Oregon model of 
Parent Management Training  for conduct problems, parent antisocial characteristics 
moderated the effect on coercive but not positive parenting practices [22]. Thus, although not 
as commonly studied, parental personality traits appear implicated in intervention response 
for childhood psychiatric problems. 
Indeed, it is well known that personality traits affect parenting practices. Maladaptive 
personality profiles, such as high levels of neuroticism (anxious or nervous; prone to stress, 
guilt, frustration and anger) and low levels of conscientiousness (reliable, rule-abiding, 
organized, achievement driven) are associated with ineffective parenting (e.g., high levels of 
negative affectivity toward children) [23-29]. Research has also documented an association 
between personality traits and coping styles, with conscientiousness predicting adaptive 
coping (e.g., problem solving), and neuroticism predicting maladaptive coping (e.g., wishful 
thinking) [30]. Thus, high maternal neuroticism and low maternal conscientiousness in 
particular may perpetuate problematic functioning in relation to both the individual and 
family, with potentially important implications for children’s treatment outcomes. 
In sum, parental personality traits may be important to consider in treatment selection 
for childhood ADHD. Indeed, prior research suggests that mothers of children with ADHD 
present with high levels of neuroticism and low levels of conscientiousness and agreeableness 
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[31-33]. In addition, the idea of a core temperamental propensity to ADHD is corroborated by 
inattention-disorganization in young adults with low levels of conscientiousness and high 
neuroticism [34].  
The current study examined the moderating effect of maternal personality traits on 
treatment response in the MTA. Based on prior literature documenting high neuroticism and 
low conscientiousness in mothers of children with ADHD [31-33], we focused on these 
personality dimensions. Individuals with high neuroticism present with increased anxiety or 
nervousness, and are prone to stress, guilt, frustration, and anger, while individuals who are 
highly conscientious tend to be reliable, rule-abiding, and achievement-driven [25,35]. We 
expected these traits to moderate treatment response, given their association with a broad 
range of variables that could influence the efficacy of interventions for children with ADHD.  
We hypothesized the following: first, children of mothers with high levels of 
neuroticism and low levels of conscientiousness would demonstrate better response to 
treatments with structured behavioral components (e.g. Beh—intensive behavioral treatment) 
than those without such structured components (e.g. CC—community comparison treatment-
as-usual) because these treatments specifically target parenting practices that may be 
problematic for mothers with this personality profile. Second, we expected that children with 
mothers possessing the opposite personality profile (low neuroticism and high 
conscientiousness) would demonstrate better response to medication (MedMgt) vs. Beh and 
CC, as these parents may already possess adequate parenting/coping skills, not requiring 
added supports.  
Method 
Sample and Procedures 
This study concerns a secondary analysis of the MTA [36-38]. The sample in the 
original study included 579 children ages 7-10 (M=8.5, SD=0.8; 19.7% female; 60.8% White) 
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meeting DSM-IV diagnostic criteria for ADHD, Combined Type. Across six sites, children 
were randomly assigned in equal proportions to medication management (MedMgt), 
intensive behavioral treatment (Beh), their combination (Comb), or community comparison 
treatment-as-usual (CC) for 14 months. MedMgt consisted of a 1-month double-blind 
titration with methylphenidate [progressing to an open titration with other medications (e.g., 
d-amphetamine, pemoline, imipramine) if methylphenidate was not better than placebo], 
followed by maintenance at the optimal dose. Beh consisted of intense, multi-component 
individual and group parent training; teacher consultation; a child-focused 8-week full-time 
summer treatment program with morning academic work and afternoon sports and social 
skills; and a 12-week half-time classroom behavioral specialist (a summer treatment 
counselor) to integrate the summer gains into the classroom. Comb integrated the MedMgt 
and Beh strategies. CC consisted of community treatment of the parents’ choosing; 2/3 
obtained medication similar to that given by the MTA but not as carefully managed and at 
lower doses. Baseline demographic and clinical characteristics across treatment conditions 
were generally negligible and non-significant.  
Participants for the current secondary analysis included 437 children whose biological 
mothers completed the NEO Five-Factor Inventory [39].  
   Study procedures were overseen by each site’s institutional review board, and 
written informed consent and assent were obtained from parents and children, respectively. 
Additional details about sampling and procedures in the MTA are described elsewhere 
[36,37]. 
Measures 
A comprehensive description of all assessments in the MTA has been outlined 
previously [40]. 
Children’s ADHD and disruptive behavior symptom severity was measured at 
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baseline and 3, 9, and 14 months via the parent- and the teacher-reported Swanson, Nolan, 
and Pelham (SNAP) rating scale [41]. The SNAP includes inattention and 
hyperactivity/impulsivity subscales and has good internal consistency, inter-rater reliability 
(between teachers and parents), and predictive validity [41,42]. It also included ratings of 
oppositional defiant disorder (ODD) symptoms on the same 0-3 metric. Because the MTA 
behavioral treatment addressed both ADHD and disruptive behavior symptoms, we included 
in our outcome variable both the 18 ADHD and the 8 ODD symptoms, using the SNAP item 
mean. Children’s diagnostic status (ODD, Anxiety) were determined through formal initial 
diagnosis using DISC-IIIR.  
Biological mothers’ mental health status was determined through report of primary 
informant (89% of informants were biological mothers) at study entry. Questions assessed 
whether the biological mother had mental health and nervous problems and type of treatment 
received, if any. 
Biological mothers’ personality traits were measured at 3 months via the NEO Five 
Factor Inventory [39]. This study focused specifically on neuroticism and conscientiousness. 
Example items are: 1) neuroticism, “I often feel tense or jittery,” and 2) conscientiousness, 
“When I make a commitment, I can always be counted on to follow through.” The NEO Five 
Factor Inventory has strong psychometric properties [43]. 
Biological mothers’ depressive symptoms were measured at baseline via the Beck 
Depression Inventory (BDI) [44]. The BDI internal consistency, test-retest reliability, and 
convergent validity have been adequately demonstrated [44]. Maternal depression was 
included because a previous qualitative ROC analysis [7] found it to be a significant 
moderator of treatment response in this sample. Biological mothers’ ADHD-related symptom 
dimensions were measured at baseline via the Conners’ Adult ADHD Rating Scales 
(CAARS) [45]. The CAARS has good internal reliability, test-retest reliability, sensitivity, 
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and specificity [46]. Consistent with other MTA analyses, empirically derived factors of 
inattention/cognitive problems, hyperactivity/restlessness, and impulsivity/emotional lability 
were examined [47]. 
Negative/ineffective discipline was measured using Hinshaw et al. [48] second order 
factor (Chronbach Alpha=.83), derived from the Alabama Parenting Questionnaire and the 
Parent Child Relationship Questionnaire first order factors.  
Statistical Analyses 
First, latent class analysis (LCA via Mplus Version 8.1) was used to estimate 
subgroups of mothers with different combinations of NEO neuroticism and conscientiousness 
scale levels. LCA identifies latent subgroups of mothers using their pattern of responses to 
NEO subscales [49,50]. BIC, entropy, parsimony, and substantive interpretability guided 
model selection. [51]     
 
Second, we evaluated if there were differences in demographics, treatment allocation, 
and child and maternal clinical characteristics between latent classes. For example, we tested 
if there were differences in the number of children with comorbid anxiety disorder, a factor 
that has been shown to predict treatment responses in previous studies [5, 52]. We also 
evaluated if there were differences in mothers’ ADHD-related symptom dimensions and 
negative/ineffective discipline between classes. We conducted these analyses in light of the 
idea that personality traits affect parenting practices, and because of the possibility of having 
a core temperamental propensity to ADHD related with a certain combination of personality 
traits [35]. 
Third, linear mixed effects modelling (LME via SAS version 9.4) was used to test the 
moderating effect of the resulting maternal personality latent classes on children’s ADHD 
symptom severity, using longitudinal SNAP measurements at baseline, 3, 9 and 14 months. 
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Models included fixed effects for time (log of the number of days since randomization in 
MTA [38]), treatment, and NEO latent classes; children’s ADHD symptom severity 
(measured via parent- and teacher-reported SNAP) as the dependent variable; and a subject-specific 
random intercept and slope. Moderation was tested using the three-way interaction of Time*NEO 
latent class*Treatment, with treatment operationalized using a set of previously developed 
orthogonal contrasts: 1) MedMgt&Comb vs. CC&Beh; 2) MedMgt vs. Comb; 3) and Beh vs. 
CC [2,53]. For NEO latent class we generated dummy variables. As a sensitivity analysis, we 
expanded the previous model incorporating maternal depression and self-report history of 
mental/nervous problems as covariates. 
Results 
Latent Class Analysis 
Comparing the fit of latent class models for 1-4 classes, a 3-class solution 
demonstrated best fit for neuroticism and conscientiousness, with a satisfactory proportion of 
mothers per class (Table 1).  
**Table 1 here** 
Figure 1 displays the three NEO neuroticism and conscientiousness classes. Mothers 
in the first class had moderate levels of neuroticism and conscientiousness (MN&MC, 
n=284, 65%). Mothers in the second class had a high level of neuroticism and a low level of 
conscientiousness (HN&LC, n=83, 19%). Mothers in the third class had a low level of 
neuroticism and a high level of conscientiousness (LN&HC, n=70, 16%).  
**Figure 1 here** 
Table 2 presents demographic, clinical information, and treatment allocation for 
children of mothers in the empirically derived classes. There were significant differences in 
depression and ADHD-related symptom dimensions, such that mothers in the HN&LC class 
reported a greater number of depressive and ADHD symptoms than mothers in other classes. 
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The HN&LC class also self-reported significantly more mental/nervous problems at baseline 
than mothers in the MN&MC and LN&HC classes. The HN&LC (and MN&MC) classes also 
showed significantly higher scores of negative/ineffective discipline than LN&HC. 
**Table 2 here** 
 
Moderation Analysis 
Parent report.  Two significant three-way interactions emerged regarding SNAP 
parent report. The largest effect occurred when comparing the treatment response between 
Beh and CC (b=-.12, se=.05, p=.009). Children of mothers in the HN&LC class who 
received Beh demonstrated a significantly better response (simple slope b=-.31, se=.04, CI=-
.39 to -.24) than children with mothers in the same class who received CC (simple slope b=-
.18, se=.04, CI=-.26 to -.11) (Figure 2, panel A). In contrast, children with mothers in the 
LN&HC class had a non-significant differential treatment response in the opposite direction: 
(Beh simple slope b=-.24, se=.04, CI=-.31 to -.16 and CC simple slope b= -.35, se=.05, CI=-
.45 to -.26) (Table 3 and Figure 2).  
**Table 3 and Figure 2 here** 
The other significant effect on parent-rated symptoms (b=-.05, se=.03, p=.04) 
reflected the main MTA outcome finding for the bulk of the sample [38] for all but the 
HN&LC group. That is, Comb&MedMgt were better than Beh&CC for MN&MC and 
LN&HC, but not for HN&LC who did better with Beh&CC (Figure 3). Children with 
mothers in the MN&MC class (over half of the sample) who received Comb&MedMgt 
demonstrated better treatment response (simple slope b=-.37, se=.02, CI=-.40 to -.33) than 
children with mothers in the same class who received Beh&CC (simple slope b=-.15, se=.02, 
CI=-.18 to -.12). Similarly, children with mothers in the LN&HC class responded better to 
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Comb&MedMgt (simple slope b=-.35, se=.03, CI=-.41 to -.29) than to Beh&CC (simple 
slope b=-.24, se=.04, CI=-.31 to -.17). 
Teacher report.  One significant three-way interaction emerged for SNAP teacher 
report (b=-.13, se=.06, p=.02). Children with mothers in the HN&LC class who received 
Comb demonstrated better treatment response (simple slope b= -.39, se=.05, CI=-.49 to -.30) 
than children with mothers in the same class who received MedMgt (simple slope b=-.22, 
se=.05, CI=-.31 to -.13). The difference between these two treatments was nonsignificant in 
the opposite direction for children with mothers in the LN&HC class (Comb simple slope 
b=-.31, se=.05, CI=-.41 to -.22; MedMgt simple slope b=-.40, se=.06, CI=-.48 to -.30) 
(Table 3 and Figure 4). 
Sensitivity Analysis 
 Two sensitivity-analysis models evaluated the robustness of aforementioned findings, 
by covarying maternal depression and self-report history of mental/nervous problems. When 
using SNAP parent report as the dependent variable (n=393), the Time*HN&LC*Beh vs. CC 
and Time*MN&MC*Comb&MedMgt vs. Beh&CC interactions remained significant (b=-.11, 
se=05, p=.03 and b=-.06, se=03, p=.02, respectively). Additionally, the Time*HN&LC*Comb 
vs. MedMgt interaction emerged as significant in this model (b=-.10, se=05, p=.03). When 
using SNAP teacher report as the dependent variable (n=392), Time*HN&LC*Comb vs. 
MedMgt interaction remained the sole significant three-way interaction (b=-.13, se=06, 
p=.03), as in the original model. 
Discussion 
This is one of the first studies to examine the moderating effect of maternal 
personality traits on treatment response for children with ADHD.  Mothers presented with 
different levels of neuroticism and conscientiousness, and mothers with high neuroticism and 
low conscientiousness (n=83/437) reported greater depressive symptoms, ADHD symptoms, 
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and mental/nervous problems than mothers with moderate or low neuroticism and moderate 
or high conscientiousness. Moreover, levels of neuroticism and conscientiousness moderated 
treatment effects. Specifically, children with mothers in the HN&LC class who received Beh 
demonstrated better response on SNAP parent report than children with mothers in the same 
class who received CC, whereas treatment response trended (nonsignificantly) in the opposite 
direction for children with mothers in the LN&HC class.  Comparing treatments involving 
medication, Comb&MedMgt were predictably better than Beh&CC for children with mothers 
in the MN&MC or LN&HC class, as was the case for the whole MTA sample [1, 36]. 
However, this well-established MTA finding was not found for the HN&LC class.  Finally, 
for SNAP teacher report, children with mothers in the HN&LC class who received Comb 
demonstrated better treatment response than children with mothers in the same class who 
received MedMgt, whereas the difference between the two treatments was actually 
nonsignificantly in the opposite direction for children with LN&HC mothers. Importantly, 
results remained significant after adjusting for maternal depression and mental/nervous 
problems.  These findings for both parent- and teacher-rated ADHD and oppositional-defiant 
symptom severity paint a picture of maternal high neuroticism and low conscientiousness 
predicting better response to behavioral treatment and relatively lesser response to 
medication. 
 The finding that mothers in the HN&LC class reported higher depression, and ADHD 
symptoms measured with the CAARS, mental/nervous problems, and negative/ineffective 
discipline is in line with prior research documenting that parents of children with ADHD 
present with high rates of depression, ADHD symptoms, and parenting stress [31,54,55], in 
addition to increased neuroticism and decreased conscientiousness [31-33].  
 In terms of moderator findings, the effect on teacher ratings suggests a real 
moderation of treatment response, not just an effect of parent personality on parent ratings. 
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Collectively, results suggest that children of mothers with high neuroticism and low 
conscientiousness may benefit most from structured behavioral treatments, either alone or 
added to medication.  High neuroticism and low conscientiousness are associated with poor 
coping [30] and ineffective parenting practices [23-29]. Because behavioral treatments 
specifically target these deficits, children of personality-impaired mothers may demonstrate 
the largest gains in response to newly implemented effective parenting strategies. In contrast, 
mothers with more adaptive personality profiles (low neuroticism and high 
conscientiousness) may have enjoyed effective parenting and coping abilities from the start, 
and thus did not benefit as much from targeted, structured interventions for these skills. 
Indeed, improvements in negative/ineffective parental discipline mediated outcomes in the 
MTA [48]. Insofar as anxious, neurotic mothers tend to have anxious children, the finding 
that children of HN&LC mothers respond relatively better to behavioral treatment than 
children of LN&HC mothers is consistent with prior MTA findings documenting that 
children with comorbid anxiety responded relatively better to behavioral treatment [38]. In 
addition, these results are consistent with structured evidence-based treatments tending to be 
most effective for children and families with the greatest impairment [21,22]. Thus, parental 
assessment prior to treatment initiation for childhood mental health problems, including 
ADHD, may help inform the most effective and optimal interventions.     
An alternate possible explanation arises from the intensive and multi-component 
nature of the MTA behavioral intervention, incorporating not only individual and group 
parent training, but also teacher consultation, a child-directed 8-week full-time summer 
treatment program, and a 12-week half-time classroom paraprofessional behavioral aide. It is 
therefore possible that the children of more impaired mothers benefitted to a greater extent 
from the consistency and support of extensive “wrap-around” services they received and not 
from parental changes per se. Further research is required to determine the mechanism 
 Maternal Personality Moderates MTA Treatment Response 
  17 
 
through which behavioral treatments and maternal personality traits interact to facilitate 
improvement in children’s ADHD symptoms.  
 Findings should also be viewed within the context of another significant parental 
moderator of MTA treatment response: parental depression. Specifically, baseline parental 
depressive symptoms were associated with worse response in MedMgt and Comb [7]. In 
these analyses, Owens et al. suggested that parental depressive symptoms may have 
interfered with children’s receipt of medication (inconsistency with doctor visits, filling 
prescriptions, administering medications), therefore thwarting the potential therapeutic effect 
of such pharmacologic intervention. In contrast, because parents received added supports and 
training via behavioral treatment, this was thought to have mitigated the negative effect of 
parental depression on children’s ADHD symptoms [7].  These prior findings are in line with 
current results, which similarly suggest that behavioral interventions may be most effective 
for mothers with coping problems. Importantly, because personality traits represent more 
stable and enduring deficits than waxing/waning psychopathology (such as depression), 
personality may be more useful to measure and consider when selecting treatment. Further 
research is needed to clarify the relation between maternal personality traits, depression, and 
children’s ADHD symptoms, as depressive symptoms may mediate the relationship between 
maternal personality and treatment response, or vice versa.  
It is interesting that the superiority of behavioral treatment for children of HN&LC 
mothers relative to children of LN&HC mothers was manifested in different orthogonal 
contrasts for parent and teacher ratings. For parent ratings, it manifested as significant 
superiority of behavioral treatment alone over routine community care, which at that time 
was mainly suboptimal medication; this was the “behavioral substitution effect”. But for 
teacher ratings, in the context of medication dramatically impacting classroom performance, 
it manifests as superiority of combination over medication alone—the “behavioral additive 
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effect”.  At the very least, findings highlight convergence of moderation findings between 
parental depression and maternal personality, though with some nuances.  
Limitations 
 Despite the strengths of this study, findings should be interpreted within the context of 
limitations. First, analyses were restricted to personality traits of biological mothers, to 
reduce potential confounds.  However, personality traits of other caregivers may also 
influence treatment response. Second, these personality traits were measured three months 
after baseline. This is not an optimal situation to test moderators. Third, there was limited 
variability in conscientiousness vs. neuroticism, which may have limited power to detect 
significant differences. Families choosing to enrol in an RCT in general may be more 
compliant and conscientious than families who opt out of RCTs. Fourth, analyses focused on 
the personality traits of neuroticism and conscientiousness, given prior literature documenting 
this profile in mothers of children with ADHD [31-33], but other personality dimensions may 
also influence treatment outcomes such as novelty seeking [56]. Fifth, biological mothers’ 
mental health status was based on self-report. Sixth, analyses were restricted only to 
participants whose biological mothers completed the NEO Five-Factor Inventory. Seventh, 
the generalizability of these findings may be limited by the intensity of the MTA behavioral 
treatment, which consisted of 35 parent training sessions, 10 teacher consultations, an 8-
week-all-day summer treatment program, and 12 weeks of a half-time paraprofessional aid in 
the classroom. Less comprehensive behavioral programs may not show the same results. 
Finally, although it is a strength that moderation findings were maintained when adjusting for 
maternal depression and mental/nervous problems, it is possible that other unmeasured parent 
variables moderated treatment response or at least partially accounted for the relationship 
observed in the current study between maternal personality and treatment response. For 
example, prior research has identified numerous other parental factors that can influence 
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children’s treatment response, including: ethnicity, marital adjustment, social class, education 
level, family composition, paternal involvement in treatment, internalizing symptoms, 
substance use, and cluster B personality disorder symptoms [5-10,19,21,22].  
Thus, future research should further explore: 1) personality in a variety of different 
caregivers; 2) if dyadic personality profiles (between two caregivers, or between caregiver 
and child) have a stronger impact on treatment response; 3) other personality dimension; 4) 
the impact of child comorbid anxiety; and 5) a wider variety of possible parent/family 
predictors and moderators. 
Clinical Implications 
Children with ADHD who have mothers with more impaired personality profiles 
(high neuroticism and low conscientiousness)—appear to benefit most from the structured 
MTA behavioral interventions (by targeting maladaptive parenting and coping via parent 
training, and/or by extensive wrap-around services including teacher consultation,  summer 
treatment program, and a classroom behavioral aide). In contrast, children of mothers with 
more adaptive personality profiles (moderate/low neuroticism and moderate/high 
conscientiousness) may experience adequate improvement in ADHD symptoms with 
pharmacotherapy alone, because these mothers are likely to be more skilled and/or have less 
room for growth. Thus, maternal personality could inform treatment planning for childhood 
ADHD (e.g., more impaired mothers may require behavioral treatments), though additional 
research is needed and other moderating factors must be considered. Nevertheless, maternal 
personality profiles may be important targets in future intervention development work. 
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